These findings collectively support the conclusion that ZNF217 modulates histone modifications in B-ALL cells through its interaction with the CoREST complex, which contributes, at least partially, to its oncogenic functions in B-ALL. This evidence concerns the gene RCOR1 and precursor B-cell acute lymphoblastic leukemia.